R. Anders
Cell Biology · 2007–2020
A researcher in the Science corpus: 12 papers; trusts 1 researcher and is trusted by 7 researchers here, as inferred from the citation graph.
Subfields
- Cell Biology — 37 citations into it; #451 of 2,073 by trust here, #357 by citations
Whom R. Anders trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts R. Anders overall
Papers from R. Anders's perspective
Ordered by how strongly the researchers R. Anders trusts endorse each paper. Same corpus, a different order for every researcher.
- Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity (Nature Medicine)
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (Science)
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
- PD-L2 is a second ligand for PD-1 and inhibits T cell activation (Nature Immunology)
- Elucidation of a universal size-control mechanism in Drosophila and mammals. (Cell)
- Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion (Nature Medicine)
- Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. (Cell)
- The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. (Cell)
- The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. (Cell)
Their papers
- Elucidation of a universal size-control mechanism in Drosophila and mammals. (2007) — 2,401 citations
- The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals (2010) — 784 citations
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. (2012) — 1,386 citations
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade (2016) — 1,956 citations
- The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution (2020) — 482 citations
- Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria (2018) — 957 citations
- A Prospective, Multi-Institutional Assessment of Four Assays for PD-L1 Expression in NSCLC by Immunohistochemistry (2017) — 718 citations
- Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy (2016) — 2,482 citations
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency (2015) — 4,624 citations
- PD-1 blockade in tumors with mismatch repair deficiency. (2015) — 4,126 citations
- Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy (2014) — 2,243 citations
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape (2012) — 2,143 citations